The Drug Rediscovery Protocol (DRUP Trial)
The Drug Rediscovery Protocol (DRUP Trial)
Recruiting · NCT02925234 · Registry updated 2024-01-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Drug Rediscovery Protocol (DRUP Trial) | cancer, neoplasm | Recruiting | Phase 2 | 2024-01-24 | NCT02925234 |
19 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amgen | 180 |
| AstraZeneca | 806 |
| Bayer | 178 |
| Boehringer Ingelheim | 158 |
| Bristol-Myers Squibb | 422 |
| Clovis Oncology - Pharma and | 1 |
| Dutch Cancer Society | 41 |
| Eisai Inc. | 40 |
| Eli Lilly and Company | 370 |
| GlaxoSmithKline | 294 |
| Incyte Corporation | 153 |
| Ipsen | 59 |
| Janssen, LP | 23 |
| Merck Sharp & Dohme LLC | 650 |
| Novartis | 114 |
| Pfizer | 431 |
| Roche Pharma AG | 59 |
| Stelvio for Life | 1 |
| The Netherlands Cancer Institute | 113 |
36 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.